Clinical trial
Efficacy and Safety Study of Pegasys in the Treatment of Chronic Hepatitis B
NCT00048945 · Hoffmann-La Roche, Industry · Completed
Key facts
| NCT number | NCT00048945 |
|---|---|
| Title | Efficacy and Safety Study of Pegasys in the Treatment of Chronic Hepatitis B |
| Lead sponsor | Hoffmann-La Roche, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Chronic Hepatitis B |
| Intervention type | Drug |
| Interventions | PEGASYS |
| Enrollment | 820 |
| Start date | Jan 1, 2002 |
| Primary completion | Oct 1, 2004 |
| Completion | Oct 1, 2004 |
| First posted | Nov 14, 2002 |
| Last update posted | Feb 17, 2017 |
| Countries | Australia, Brazil, Canada, China, France, Germany, Israel, New Zealand, Poland, Puerto Rico, Singapore, South Korea and 5 more |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: